RNA interference protocol to silence oncogenic drivers in leukemia cell lines

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Silencing

Background:

• Delivering small interfering RNAs (siRNAs) to leukemia cells for gene silencing is challenging.
• High transfection efficiency and cell viability are critical for functional studies of leukemia-associated proteins.

Purpose of the Study:

• To describe an efficient protocol for silencing oncogenic feline McDonough sarcoma (FMS)-like tyrosine kinase-3 in leukemia cells.
• To provide a generally applicable method for decreasing RNA levels of proteins of interest in leukemia cells.

Main Methods:

• Utilized small interfering RNAs (siRNAs) for genetic silencing.
• Employed electroporation as the delivery method for siRNAs into leukemia cells.
• Focused on silencing feline McDonough sarcoma (FMS)-like tyrosine kinase-3.

Main Results:

• Achieved efficient siRNA delivery to leukemia cells.
• Maintained high cell viability throughout the transfection process.
• Successfully demonstrated the silencing of target oncogenic proteins.

Conclusions:

• The described electroporation protocol is an effective strategy for siRNA delivery in leukemia cells.
• This method facilitates functional studies of leukemia-associated proteins by enabling efficient gene silencing.
• The protocol is adaptable for silencing various RNAs encoding proteins of interest in cancer research.